Literature DB >> 16096947

Reconstruction of the form and function of lateral malleolus and ankle joint.

Kensuke Kiyokawa1, Shinsuke Tanaka, Yuichiro Kiduka, Yojiro Inoue, Toshihiko Yamauchi, Yoshiaki Tai.   

Abstract

Soft-tissue reconstruction alone cannot obtain normal ankle function in patients with large defects in the area of the lateral malleolus. The authors report a functional reconstructive method for the lateral malleolus, utilized in a male patient whose osteosarcoma in the fibula was resected with surrounding soft tissue. In order to reconstruct the lateral malleolus, the remaining half of the fibula at the knee was removed, and the fibular head was fixed with the tibia at the ankle joint. Ligaments were reconstructed with tendon grafts. Skin and soft-tissue defects were reconstructed with a combined composite flap comprised of a latissimus dorsi myocutaneous flap and a serratus anterior muscle flap. Dead space around the bone graft was filled with the serratus anterior muscle flap that was divided into two portions. The surface was covered with the latissimus dorsi myocutaneous flap. The patient regained almost normal function of the ankle joint. This technique would be a useful functional reconstructive method for patients with large defects in the area of the lateral malleolus.

Entities:  

Mesh:

Year:  2005        PMID: 16096947     DOI: 10.1055/s-2005-915204

Source DB:  PubMed          Journal:  J Reconstr Microsurg        ISSN: 0743-684X            Impact factor:   2.873


  2 in total

1.  A retrospective analysis of latissimus dorsi-serratus anterior chimeric flap reconstruction in 47 patients with extensive lower extremity trauma.

Authors:  Ravi Kumar Mahajan; Krishnan Srinivasan; Abhiskek Bhamre; Mahipal Singh; Prakash Kumar; Ankush Tambotra
Journal:  Indian J Plast Surg       Date:  2018 Jan-Apr

2.  Compound grafting of residual vascularized fibular head flap to reconstruct contralateral lateral malleolus: A case report.

Authors:  Peiji Wang; Man-Yi Cui; Jiaju Zhao; Jun Lv
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.